Published in

American Association for Cancer Research, Cancer Discovery, 4(14), p. 643-647, 2024

DOI: 10.1158/2159-8290.cd-23-1543

Links

Tools

Export citation

Search in Google Scholar

Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME

Journal article published in 2024 by Tri Giang Phan ORCID, Katherine N. Weilbaecher ORCID, Rebecca Aft ORCID, Peter I. Croucher ORCID, Christine L. Chaffer ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Summary: Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.